(Q72103996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

S Pyrhönen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

R Valavaara

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J Vuorinen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A Hajba

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

223-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00666475

23 October 2019

exact match

0 references

cites work

Alternative mechanism of action of "anti-oestrogens" in breast cancer

1 reference

12 December 2020

High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer. An ongoing phase II multicenter Finnish-Latvian cooperative study

1 reference

12 December 2020

Phase I study of toremifene in patients with advanced cancer

1 reference

12 December 2020

A new triphenylethylene compound, Fc-1157a. II. Antitumor effects.

1 reference

12 December 2020

Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study

1 reference

12 December 2020

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

1 reference

12 December 2020

Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication.

1 reference

12 December 2020

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta

1 reference

12 December 2020

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer

1 reference

12 December 2020

Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer

1 reference

12 December 2020

Phase III studies of toremifene in metastatic breast cancer.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene

1 reference

12 December 2020

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00666475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8049456%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference